Pages that link to "Q44059818"
Jump to navigation
Jump to search
The following pages link to Atypical neuroleptics stimulate neurogenesis in adult rat brain (Q44059818):
Displaying 50 items.
- Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia (Q22241430) (← links)
- Rethinking psychopharmacotherapy: The role of treatment context and brain plasticity in antidepressant and antipsychotic interventions (Q26776255) (← links)
- Effects of antipsychotics on dentate gyrus stem cell proliferation and survival in animal models: a critical update (Q26823735) (← links)
- The NPAS3 gene--emerging evidence for a role in psychiatric illness (Q28265950) (← links)
- A longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophrenia (Q28539784) (← links)
- The adaptive significance of adult neurogenesis: an integrative approach (Q28678030) (← links)
- Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia (Q30375799) (← links)
- Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection (Q30386608) (← links)
- Adult neurogenesis and mental illness (Q30395004) (← links)
- Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal (Q30460361) (← links)
- Regulation of adult neurogenesis in the hippocampus by stress, acetylcholine and dopamine (Q30468855) (← links)
- Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis (Q30977943) (← links)
- Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation (Q33238062) (← links)
- Neuroprotection and enhancement of neurite outgrowth with small molecular weight compounds from screens of chemical libraries (Q33267049) (← links)
- Tracing the development of psychosis and its prevention: What can be learned from animal models (Q34195256) (← links)
- Effects of 4-weeks of treatment with lithium and olanzapine on long-term potentiation in hippocampal area CA1 (Q34285267) (← links)
- Dopamine depletion impairs precursor cell proliferation in Parkinson disease. (Q34326801) (← links)
- Neurogenic actions of atypical antipsychotic drugs and therapeutic implications (Q34662630) (← links)
- Lithium, but Not Fluoxetine or the Corticotropin-Releasing Factor Receptor 1 Receptor Antagonist R121919, Increases Cell Proliferation in the Adult Dentate Gyrus (Q34715718) (← links)
- Targeting the hippocampal mossy fiber synapse for the treatment of psychiatric disorders. (Q34917667) (← links)
- Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia (Q35390344) (← links)
- Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders (Q35618437) (← links)
- 13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients (Q36001621) (← links)
- G-Protein-Coupled Receptors in Adult Neurogenesis (Q36105469) (← links)
- Olanzapine: a critical review of recent literature (Q36273449) (← links)
- Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness (Q36390750) (← links)
- Neuroprotective agents in schizophrenia and affective disorders (Q36458436) (← links)
- Psychotherapy for schizophrenia in the year 2030: prognosis and prognostication (Q36564586) (← links)
- Dopamine and adult neurogenesis (Q36652288) (← links)
- Evidence for neuroprotective effects of antipsychotic drugs: implications for the pathophysiology and treatment of schizophrenia (Q36687842) (← links)
- Neurogenesis and neuroenhancement in the pathophysiology and treatment of bipolar disorder (Q36687844) (← links)
- Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications (Q36703795) (← links)
- The case for long-acting antipsychotic agents in the post-CATIE era. (Q36758680) (← links)
- 5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression (Q36793918) (← links)
- Neurogenesis and schizophrenia: dividing neurons in a divided mind? (Q36806465) (← links)
- Cell proliferation is reduced in the hippocampus in schizophrenia (Q36830548) (← links)
- Neurotransmitter-mediated control of neurogenesis in the adult vertebrate brain (Q36883223) (← links)
- Novel uses for risperidone: focus on depressive, anxiety and behavioral disorders (Q36904901) (← links)
- Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology (Q37163613) (← links)
- Increased hippocampal neurogenesis and p21 expression in depression: dependent on antidepressants, sex, age, and antipsychotic exposure (Q37172784) (← links)
- MPTP Impairs Dopamine D1 Receptor-Mediated Survival of Newborn Neurons in Ventral Hippocampus to Cause Depressive-Like Behaviors in Adult Mice (Q37335443) (← links)
- Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models. (Q37446674) (← links)
- Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. (Q37541981) (← links)
- Synapsin III: Role in neuronal plasticity and disease (Q37914375) (← links)
- Neuroinflammation in schizophrenia especially focused on the role of microglia (Q37970863) (← links)
- Improving myelin/oligodendrocyte-related dysfunction: a new mechanism of antipsychotics in the treatment of schizophrenia? (Q38060893) (← links)
- Drug discovery based on genetic and metabolic findings in schizophrenia (Q38177357) (← links)
- Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis (Q38258215) (← links)
- Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampus. (Q38399332) (← links)
- Role of adult hippocampal neurogenesis in cognition in physiology and disease: pharmacological targets and biomarkers (Q38482062) (← links)